Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial
Introduction Neonatal hypoxic-ischaemic encephalopathy (HIE) is an important illness associated with death or cerebral palsy. This study aims to assess the safety and tolerability of the allogenic human multilineage-differentiating stress-enduring cell (Muse cell)-based product (CL2020) cells in new...
Үндсэн зохиолчид: | Akihiro Hirakawa, Masahiko Ando, Masahiro Hayakawa, Nao Matsuyama, Shinobu Shimizu, Kazuto Ueda, Toshihiko Suzuki, Sakiko Suzuki, Ryosuke Miura, Akemi Katayama, Masaaki Mizuno, Yoshiaki Sato |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
BMJ Publishing Group
2022-04-01
|
Цуврал: | BMJ Open |
Онлайн хандалт: | https://bmjopen.bmj.com/content/12/4/e057073.full |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic–ischemic brain injury in neonatal rats
-н: Kazuto Ueda, зэрэг
Хэвлэсэн: (2023-09-01) -
Incidence of hypoxic-ischaemic encephalopathy and use of therapeutic hypothermia in Spain
-н: Juan Arnaez, зэрэг
Хэвлэсэн: (2018-07-01) -
Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data
-н: Edwards, A, зэрэг
Хэвлэсэн: (2010) -
Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial.
-н: Rutherford, M, зэрэг
Хэвлэсэн: (2010) -
THE EXPERIENCE OF USING LOW-TECHNOLOGY HYPOTHERMIA IN THE NEWBORN WITH SEVERE HYPOXIC ISCHAEMIC ENCEPHALOPATHY
-н: A. A. Zadvornov, зэрэг
Хэвлэсэн: (2017-12-01)